Analysis reveals rise in claim denial rates for cancer-related advanced genetic testing

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing...

Get In Touch

123 Street, New York, USA

+012 345 67890

info@example.com

Follow Us
Flickr Photos

Copyright © 2023 galaxy11. All Rights Reserved